Low early posttransplant serum tacrolimus levels are associated with poor patient survival in lung transplant patients

BACKGROUND: Low-dose tacrolimus-based immunosuppression is a standard therapy in kidney and liver transplantation; however, the optimal therapeutic level of tacrolimus has not been established in lung transplantation. We aimed to identify the tacrolimus level associated with better outcomes in lung...

Descripción completa

Detalles Bibliográficos
Autores principales: Ryu, Jung-Hwa, Choi, Sunmi, Lee, Hyun Joo, Kim, Young Tae, Kim, Young Whan, Yang, Jaeseok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611203/
https://www.ncbi.nlm.nih.gov/pubmed/31333768
http://dx.doi.org/10.4103/atm.ATM_160_18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611203/
https://www.ncbi.nlm.nih.gov/pubmed/31333768
http://dx.doi.org/10.4103/atm.ATM_160_18

Ejemplares similares